A
ADMA icon

AlphaQuest’s ADMA Biologics ADMA Stock Holding History

AlphaQuest’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,677
Closed -$30.6K – 35
2025
Q4 		$30.6K Sell
1,677
-1,492
-47% -$25.1K ﹤0.01% 2035
2025
Q3 		$46.5K Buy
+3,169
New +$54.3K ﹤0.01% 1955
2025
Q2 		– Sell
-929
Closed -$18.4K – 2000
2025
Q1 		$18.4K Sell
929
-3,995
-81% -$69.1K ﹤0.01% 1716
2024
Q4 		$84.4K Buy
+4,924
New +$92.6K 0.01% 1141
2024
Q3 		– Sell
-2,630
Closed -$29.4K – 1866
2024
Q2 		$29.4K Buy
+2,630
New +$22.1K ﹤0.01% 1245

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AlphaQuest's ADMA Position: Q1 2026 in Review

AlphaQuest sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 1,677 shares — an estimated $30.6K sold.

AlphaQuest first reported a position in ADMA in Q2 2024 and held it in 5 quarters. The position peaked at $84.4K in Q4 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • AlphaQuest reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 1,677 ADMA Biologics shares in Q1 2026, an estimated $30.6K.
  • AlphaQuest first reported a position in ADMA Biologics in Q2 2024 and held it in 5 quarters.
  • AlphaQuest's ADMA Biologics position peaked at $84.4K in Q4 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.